Literature DB >> 7473706

Solution structure of the anticodon-binding domain of Escherichia coli lysyl-tRNA synthetase and studies of its interaction with tRNA(Lys).

S Commans1, P Plateau, S Blanquet, F Dardel.   

Abstract

A protein domain corresponding to residues 31 to 149 of the E. coli Lysyl-tRNA synthetase species corresponding to the lysS gene was expressed and 15N-labelled. 1H and 15N NMR resonance assignments for this domain were obtained by two-dimensional and three-dimensional homonuclear and heteronuclear spectroscopy. Using distance geometry and simulated annealing, a three-dimensional structure could be calculated using 701 NOE and 86 dihedral angle restraints. It is composed of a five-stranded antiparallel beta-barrel capped by three alpha-helices at its ends. This structure closely resembles that of the N-terminal domain of the other E. coli lysyl-tRNA synthetase species expressed from the lysU gene and is highly homologous to the fold observed for the corresponding region of aspartyl-tRNA synthetase. It is shown that the isolated N-terminal fragment of lysyl-tRNA synthetase can interact with tRNA(Lys) as well as with poly (U), which mimics the anticodon sequence. Amino acid residues involved in these interactions were identified and, in the case of poly-U, a number of specific protein-RNA contacts were characterized. Specific recognition of tRNA(Lys) involves a cluster of four structurally well-defined aromatic residues, anchored on the beta-strands, and basic residues located on the surrounding loops. This organization is reminiscent of other RNA binding proteins, such as the U1A small nuclear ribonucleoprotein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473706     DOI: 10.1006/jmbi.1995.0539

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  18 in total

Review 1.  Nucleic acid recognition by OB-fold proteins.

Authors:  Douglas L Theobald; Rachel M Mitton-Fry; Deborah S Wuttke
Journal:  Annu Rev Biophys Biomol Struct       Date:  2003-02-18

2.  Conformational change of Escherichia coli initiator methionyl-tRNA(fMet) upon binding to methionyl-tRNA formyl transferase.

Authors:  Christine Mayer; Uttam L RajBhandary
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

3.  NMR assignments for acid-denatured cold shock protein A.

Authors:  A T Alexandrescu; K Rathgeb-Szabo
Journal:  J Biomol NMR       Date:  1998-05       Impact factor: 2.835

4.  Crystal structure at 1.2 A resolution and active site mapping of Escherichia coli peptidyl-tRNA hydrolase.

Authors:  E Schmitt; Y Mechulam; M Fromant; P Plateau; S Blanquet
Journal:  EMBO J       Date:  1997-08-01       Impact factor: 11.598

Review 5.  Emergence and evolution.

Authors:  Tammy J Bullwinkle; Michael Ibba
Journal:  Top Curr Chem       Date:  2014

6.  Crystal structure of trbp111: a structure-specific tRNA-binding protein.

Authors:  M A Swairjo; A J Morales; C C Wang; A R Ortiz; P Schimmel
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

7.  Structure of crystalline Escherichia coli methionyl-tRNA(f)Met formyltransferase: comparison with glycinamide ribonucleotide formyltransferase.

Authors:  E Schmitt; S Blanquet; Y Mechulam
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

8.  Anticodon recognition and discrimination by the alpha-helix cage domain of class I lysyl-tRNA synthetase.

Authors:  Jeffrey D Levengood; Hervé Roy; Ryuichiro Ishitani; Dieter Söll; Osamu Nureki; Michael Ibba
Journal:  Biochemistry       Date:  2007-08-31       Impact factor: 3.162

9.  Rational design of an orthogonal tryptophanyl nonsense suppressor tRNA.

Authors:  Randall A Hughes; Andrew D Ellington
Journal:  Nucleic Acids Res       Date:  2010-06-22       Impact factor: 16.971

10.  Partially folded states of staphylococcal nuclease highlight the conserved structural hierarchy of OB-fold proteins.

Authors:  Emma Watson; William M Matousek; Evelyn L Irimies; Andrei T Alexandrescu
Journal:  Biochemistry       Date:  2007-07-28       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.